N/A
N=1,499
The Pharmacist Follows You and Your Medication From Hospital to Your Daily Life and Investigate What This Means to You
Cross-Sectional Study
Bottom Line
View on ClinicalTrials.gov: NCT03079375 ↗Enrolled (actual)
1,499
Serious AEs
—
Results posted
Dec 2019
Primary outcome: Primary: Readmissions — 111; 98; 68 Participants
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- basic intervention (Other); extended intervention (Other)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- Lene V. Ravn-Nielsen
- Primary completion
- Apr 2015
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Readmissions |
111; 98; 68 | — |
| PRIMARY Admissions |
243; 233; 189 | — |
| PRIMARY Emergency Department Visits |
21; 19; 15 | — |
| PRIMARY Composite Endpoint, Admissions or Emergency Department Visits |
243; 233; 193 | — |
| SECONDARY Drug-related Admissions |
96; 95; 75 | — |
| SECONDARY Drug-related Readmissions |
38; 34; 24 | — |
| SECONDARY Percentage of Medication Changes Accepted by GPs |
66 | — |
| SECONDARY Medication Review Changes Accepted by Physicians (in Hospital) |
61; 61 | — |
| SECONDARY Mortality |
50; 42; 54 | — |
| SECONDARY Drug Related Mortality |
6; 3; 5 | — |
Summary
Background
It is well known that the transfer of a patient from hospital to the general practitioner is related with mistakes in the medication of the patient. A report from 2006 measure the number of drug related admissions in Denmark to be 69.000 to 162.000 per year. To reduce these mistakes, more and better communication between the health professionals are suggested. Furthermore medication reviews made by pharmacist seems to reduce the number of drug related readmissions and other drug related issues, which can lead to an economic cost reduction.
Objective
The aim of this study is to investigate the impact of medication review and better communication between the health professionals after discharge of a patient from hospital to the general practitioner. The effect is measured as reducing the number of readmissions and number of visits at the emergency department 30 days and six month after inclusion of the patient.
Method
This study was estimated to include 1500 participants. The patients were randomized to one of three groups; usual care, basic intervention or extended intervention. The usual care received the normal care following the Danish standard procedure. The basic intervention had a medication review by a clinical pharmacist during admission.
The extended interventions group was similar to the basic intervention group plus follow-up with the patient, the general practitioner and if relevant the nursing home and pharmacy one week and six month after discharge by interview with the clinical pharmacist.
Eligibility Criteria
Inclusion Criteria
- Usual medicine of five drugs or above
- Speak and understand Danish
- Admitted via the Acute Medicine Admission Ward
- Are able to give informed consent
Exclusion Criteria
- Patients included in a similar study
- Declared terminal
- Suicidal
- In custody
- Isolated at the hospital
- Im- and/or expressive aphasia
- Severe dementia
Data sourced from ClinicalTrials.gov (NCT03079375). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.